Purpose Lower limb lymphedema (LLL) is a common condition after pelvic cancer treatment but few studies have evaluated its effect on the quality of life and its consequences on daily life activities among gynecological cancer survivors. Methods We identified a cohort of 789 eligible women, treated with pelvic radiotherapy alone or as part of combined treatment of gynecological cancer, from 1991 to 2003 at two departments of gynecological oncology in Sweden. As a preparatory study, we conducted in-depth interviews with gynecological cancer survivors and constructed a studyspecific questionnaire which we validated face-to-face. The questionnaire covered physical symptoms originating in the pelvis, demographic, psychological, and quality of life factors. In relation to the lymph system, 19 questions were asked. Results Six hundred sixteen (78 %) gynecological cancer survivors answered the questionnaire and participated in the study. Thirty-six percent (218/606) of the cancer survivors reported LLL. Overall quality of life was significantly lower among cancer survivors with LLL. They were also less satisfied with their sleep, more worried about recurrence of cancer, and more likely to interpret symptoms from the body as recurrence. Cancer survivors reported that LLL kept them from physical activity (45 %) and house work (29 %) and affected their ability to partake in social activities (27 %) or to meet friends (20 %). Conclusion Lower limb lymphedema has a negative impact on quality of life among gynecological cancer survivors, affecting sleep and daily life activities, yet only a few seek professional help.
Introduction
Globally, gynecological cancer accounts for 17 % of all female cancers; while in Europe, the estimated 5-year prevalence of gynecological cancer is around 14 %, indicating about 670,000 female cancers [1] . Many cancer survivors have been treated with pelvic radiotherapy, given alone or in combination with chemotherapy or surgery, and they report symptoms from the gastrointestinal tract (e.g., diarrhea, defecation urgency, and fecal incontinence) [2] [3] [4] , the urinary bladder (e.g., urgency and urinary incontinence) [3] , the vagina (e.g.; vaginal changes, dyspareunia) [5] , and the pelvic bones (e.g., pain) [6] , resulting in decreased physical functioning and lowered quality of life [3, 7] .
Pelvic radiotherapy and surgical lymph node dissection are also associated with a risk of lymphedema in the lower limbs (LLL) as well as the genital region [8, 9] . The reported incidence of LLL varies between 7 and 78 % [8] [9] [10] [11] , with the highest incidence among patients treated with radiotherapy alone [12] . The large discrepancy in reported incidence may be attributable to difficulties in establishing a strict definition of lymphedema, potential reporting bias, and differences in follow-up time [13] .
Lymphedema is a chronic and incurable condition which causes functional and esthetic defects. Studies in the field of breast cancer research, a more extensively studied field, show negative impact of upper limb lymphedema on daily activities as well as on social life, involving psychological stress leading to reduced quality of life [14, 15] . Although LLL is a common condition after pelvic cancer treatment, few studies have evaluated its effect on quality of life, on sleep, sexuality, and daily life activities among gynecological cancer survivors.
We performed a population-based study on long-term symptoms after pelvic radiotherapy among 616 gynecological cancer survivors [16] . In the present study, we describe the impact of LLL on the overall quality of life, sleep, sexuality, and daily life activities reported by gynecological cancer survivors.
Patients and methods

Study population
We identified a cohort of 1,800 women treated between 1991 and 2003 with external pelvic radiotherapy for a gynecological malignancy at Radiumhemmet, Karolinska University Hospital in Stockholm, or at Jubileumskliniken, Sahlgrenska University Hospital in Gothenburg of whom 1,303 were alive in 2006. After excluding patients that did not meet the eligibility criteria of being born 1927 or later, being able to read and understand Swedish, and not having experienced a recurrence of their malignancy, 789 patients remained and were invited to participate.
Among the gynecological cancer survivors, 616 (78 %) returned a completed questionnaire (Fig. 1) . Fifty-nine percent of the survivors had a history of endometrial cancer; 23 % of cervical cancer; 7 % of ovarian cancer; 5 % of uterine sarcoma; and the remaining 5 % of vaginal cancer, fallopian tube cancer, and vulvar cancer.
Ninety percent of all cancer survivors received pelvic radiotherapy in addition to surgery and 10 % were treated with radiotherapy alone. In 17 % of the cancer survivors, pelvic lymphadenectomy was performed during surgery. Brachytherapy was given to 80 % of the cancer survivors and 33 % received chemotherapy-in some cases, concomitant with radiotherapy [16] .
As controls, we recruited 486 women from the Swedish Population Register, matched for age and residency and who had not had pelvic radiotherapy. A detailed description of the study population is provided in a recent publication [16] . The regional ethic committees approved the study.
Questionnaire
Our methods for studies of cancer survivorship and development of a study-specific questionnaire have been documented in more than 80 scientific papers [5, 17] . A description of the development and validation of the present questionnaire has been reported [2] . In summary, the questionnaire was developed during a qualitative phase lasting 18 months. In this phase, cancer survivors were interviewed until no new information could be identified and in total, 26 women shared their experiences. Based on the interviews, a study-specific questionnaire was constructed. It consisted of 351 questions and covered symptoms from the gastrointestinal tract, the urinary bladder, the genitals, the lymphatic system, the pelvic bones, and the legs; questions concerning demographics, sexual function, psychological and quality-of-life issues, as well as social functioning were included. Where appropriate, each part of the constructed questionnaire asked about the incidence, prevalence, intensity, and duration of the symptoms. In relation to the lymph system, 19 questions were asked. For example: "Have you had swelling in your legs during the past 6 months?" with the possible answers "No"; "Yes, occasionally"; "Yes, at least once a month"; "Yes, at least once a week"; "Yes, at least three times a week"; and "Yes, at least once a day."
The final version was tested for face validity in 20 individuals. The questionnaire was thereafter tested in a pilot study including yet another 20 gynecological cancer survivors within the study population. We obtained a participation rate of 80 %, which was regarded as sufficient to continue with the main study. The main study, the quantitative phase, was carried out in January to October 2006. Eligible women that gave informed consent received a postal questionnaire. To maintain anonymity, each questionnaire contained a number for identification.
Medical records were reviewed to confirm the cancer diagnosis, stage of disease, and treatment modalities regarding surgery, radiotherapy, and chemotherapy. Patients with recurrent disease were excluded. Treatment was carried out according to current local treatment programs and applied study protocols that were ongoing at the time of treatment. These protocols and recommendations have changed over the studied period.
Statistical analysis
The results from the questionnaire and the data from medical records were coded and transferred to the freeware data entry and validation program EpiData (www.epidata.dk). Ninetyeight percent (606/616) of the cancer survivors answered the question "Have you had swelling in your legs during the past 6 months?" and 36 % (218/606) were defined as having LLL. The symptom LLL was dichotomized into having had the symptom "at least occasionally" the past 6 months, or not having had the symptom. In Table 1 , we show characteristics of the cancer survivors with and without LLL. Differences in characteristics were investigated with t tests for continuous, and Fisher's exact test (Monte Carlo approximation, 1,000,000 samples) for categorical variables. In Table 2 , we give relative risks (risk ratios (RR)), calculated using log-linear regression.
Individuals with missing data were excluded for each calculation. All tests were performed at 5 % significance level, and the calculations were done using the SAS statistical software package (version 9.3, SAS Institute Inc., Cary, NC, USA).
Results
Characteristics and treatment
Among the survivors, 218/606 (36 %) reported lower limb lymphedema. Cancer survivors with LLL were somewhat younger (mean age 62.5) than survivors without LLL (mean age 65.3) and were also employed to a higher extent than survivors without LLL (38 versus 30 %). Furthermore, cancer survivors with LLL were more likely to be receiving disability pension than survivors without LLL. No differences were seen for smoking or exercise habits. In the group of cancer survivors with LLL, we found a higher percentage of women with a body mass index (BMI) of 30 or higher (27 versus 11 %), presented in Table 1 .
Physical symptoms from the pelvic region
Cancer survivors with LLL reported a higher prevalence of fecal incontinence at least occasionally during the previous 6 months (56 %) than survivors without LLL (46 %), with a RR of 1.2, 95 % confidence interval (CI) 1.0-1.4. Affected survivors also had a higher prevalence of urinary urgency (26 versus 16 %), RR 1.6, 95 % CI 1.2-2.3 as well as urinary incontinence (68 versus 52 %), RR 1.3, 95 % CI 1.2-1.5.
Quality of life and daily life activities
Overall quality of life was significantly lower among cancer survivors with LLL, after adjusting for age, fecal incontinence, urinary urgency, and incontinence, with a RR of 1.4, 95 % CI 1.2-1.6. Affected women were less satisfied with their sleep, RR 1.3, 95 % CI 1.0-1.5. They worried more about recurrence of cancer, RR 1.3, 95 % CI 1.1-1.5, and they were more likely to interpret symptoms and signals from their bodies as indicating recurrence, RR 1.4, 95 % CI 1. Fig. 1 Flow chart of the inclusion of gynecological cancer survivors sexuality and the prevalence of feeling attractive as a woman did not differ between the two groups ( Table 2 ). The survivors reported that LLL had a negative impact on several daily life activities. Forty-five percent of the survivors reported that they (5) a Current BMI at the time the questionnaire was completed. Percentage may not total to 100 because of rounding avoided exercise, 27 % avoided social activities such as going to the cinema, theater, etc., and 20 % avoided meeting friends due to LLL (Fig. 2) .
Triggering factors
Gynecological cancer survivors with LLL reported that the following activities: standing and walking (77 %), sitting still (65 %), exercise (14 %), excessive drinking (11 %), sauna/heat (29 %) and having infections (13 %) worsened their lower limb lymphedema (Fig. 3) .
Treatment
Survivors reported the following treatments and activities in order to reduce LLL: elevated limb (75 %), compression (50 %), diuretics (27 %), lymphedema treatment (9 %), physiotherapy (9 %), and self-care programs (12 %). Thirty-one percent had actively sought health care due to lymphedema (Fig. 4) .
Discussion
In this large population-based study of long-term gynecological cancer survivors treated with pelvic radiotherapy alone or as part of combined treatment modality, lower limb lymphedema had an effect on overall quality of life, sleep, and daily life activities. A majority of the studied cancer survivors also worried about and interpreted bodily sensations as indicating a recurrence of the cancer. Additionally, concomitant symptoms such as urinary-and fecal incontinence were more prevalent among the gynecological cancer survivors with lower limb lymphedema. Previous findings on lymphedema after cancer treatment and its effect on quality of life have mainly focused on the field of breast cancer [14, 18, 19] . In a large study of almost 1,300 women with a history of breast cancer, Ahmed et al. found that the health-related quality of life was significantly lower in breast cancer survivors with diagnosed lymphedema or with arm symptoms but without diagnosed lymphedema, compared with survivors without lymphedema or arm symptoms [14] . Similar research on lower limb lymphedema and quality of life after gynecological cancer treatment is limited. However, Beesley et al. studied 802 gynecological cancer survivors, who had been diagnosed with cervical, uterine, ovarian, and other gynecological cancers. As in our study, the investigators used a self-reported validated questionnaire based on earlier qualitative findings. A set of questions to determine lymphedema status as well as to capture the experience of having LLL was used [8] . They found the levels of unmet need to be considerably higher among the affected cancer survivors compared with women with no LLL. Among the highest ranked needs was "needing help with fear of cancer spreading" [20] . The fear of cancer spreading was also observed among a significant proportion of cancer survivors in our study. When living with a fear of recurrence, we believe physical symptoms are easily interpreted as indicating a recurrence of cancer. Symptoms of early lymphedema include tightness, swelling, heaviness, and marks from clothing. Early symptoms of lymphedema are ambiguous and easily overlooked by physicians [21] and other health care professionals. If progressed LLL may cause pain and decreased muscle strength, survivors with lymphedema are more susceptible to infection [10] . The majority, more than 70 % of gynecological cancer survivors in our study with LLL, also reported low to moderate satisfaction with sleep. Insufficient quality and quantity of sleep are associated with physical and psychological disorders [22] . We can only speculate about the reason for this insomnia among the survivors with LLL. Symptoms such as swelling, pain, and heaviness most likely have a negative impact on sleep. Dahl et al. studied sleep and lymphedema among 337 breast cancer survivors with arm/shoulder pain, 3.9 years after surgery combined with adjuvant radiotherapy and chemotherapy/hormones. Among the breast cancer survivors, arm/shoulder pain, lymphedema, and restricted mobility were all associated with insomnia, with pain as the most strongly associated [23] . Furthermore, if bodily sensations such as swelling and pain are not recognized and diagnosed as lymphedema, they may easily be interpreted as indicating the recurrence of cancer. The consequent anxiety and worry may have a negative impact on sleep. Lymphedema develops when the lymphatic system is unable to adequately support lymphatic circulation, resulting in excess accumulation of fluid [24] . Radiotherapy and surgical lymphadenectomy have been implicated as causative factors [9] . Pelvic radiotherapy may cause lymphedema by preventing the formation of collateral circulation of the lymphatic system and by accelerating skin fibrosis [25, 26] . Additional risk factors for lymphedema are BMI higher than 30 and a decreased physical health condition [8, 26] . In our study, a larger proportion of cancer survivors with LLL, reported BMI higher than 30. This result is in line with other studies that include cancer survivors with LLL [8] .
We also found that concomitant symptoms such as urinary and fecal incontinence were more prevalent among the gynecological cancer survivors with LLL. To our knowledge, this is the first study to report on concomitant symptoms such as incontinence of feces and urine among gynecological cancer survivors with LLL. We know from previous studies that survivors with fecal leakage have a lower quality of life and that it strongly affects daily life functioning [7] , even after adjusting for confounding factors.
The recommended treatment for LLL is complete decongestive therapy. This requires a life-long commitment to wearing a graduated pressure elastic garment during the day and to performing specific remedial exercises every day. The treatment of lymphedema must be individualized, taking personal experiences of the condition and psychosocial situation into account [27] . If left untreated, lymphedema is likely to progress [28] and put cancer survivors at risk for severe swelling, skin changes, fibrosis, and infections [10] .
Patients need to be informed about the risk of LLL before initiating cancer treatment, and presumably, they need to be reminded again during as well as after treatment. Equally important is to educate affected survivors in how to begin management of the LLL at an early stage and how to protect the lower limbs from infection or trauma [11] . Our results illuminate the importance of patient education as a majority of the cancer survivors believed walking and exercising might trigger lymphedema. In contrast, studies on breast cancer survivors have shown the importance of physical activity. Schmitz et al. found in a study of 154 breast cancer survivors that slow progressive-weight lifting resulted in a decreased incidence of exacerbations of lymphedema, reduced symptoms, and increased strength [29] . It is reasonable to believe that this finding may be applicable to gynecological cancer survivors.
Among the strengths of this report is the method of using a validated instrument developed in close cooperation with gynecological cancer survivors, which we believe has had a great impact. In addition, the questionnaire was completed in the privacy of the respondent's home and in confidence; this may lower the risk of potential interviewer-induced bias. The fact that the research team is independent from the clinic may further decrease the risk of bias.
Even though our study has several strengths, it still has limitations that need to be mentioned. Despite the highparticipation rate, we lack information about the nonparticipants. In previous studies, our research team has found that individuals older than 80 years of age have a tendency to decline participation. For this reason, we did not include women over 80 and consequently, we cannot extrapolate our findings to the very elderly cancer survivors. Finally, the studies were carried out in Sweden and we do not know to what extent our findings are applicable to other populations and cultures outside Sweden.
The findings of our study highlight the significance of lower limb lymphedema and the impact it has on daily living and quality of life. It is important to take action and actively ask pelvic cancer patients about signs and symptoms of pain, swelling, and heaviness in the pelvic region after treatment in order to help them to get early treatment or refer them to experts in this field.
